View More Recent Stories

Jan 6, 2025 02:00PM 7 top biotech picks for 2025 according to Wells Fargo
Jan 2, 2025 04:00PM Biotech outlook for 2025: Stifel
Jan 2, 2025 10:56AM Stifel Highlights Iovanace Biotherapeutics (IOVA) as 'Top Pick' in Biotech's 2025 Outlook Note
Nov 26, 2024 04:02PM Iovance Biotherapeutics (IOVA) Promotes Raj Puri to Chief Regulatory Officer
Nov 7, 2024 04:08PM Iovance Biotherapeutics (IOVA) Tops Q3 EPS by 2c
Oct 24, 2024 03:53AM UBS Starts Iovanace Biotherapeutics (IOVA) at Buy
Sep 12, 2024 07:45AM Baird Reiterates Outperform Rating on Iovanace Biotherapeutics (IOVA)
Aug 14, 2024 02:15PM TD Cowen Reiterates Buy Rating on Iovanace Biotherapeutics (IOVA)
Aug 9, 2024 07:56AM Iovanace Biotherapeutics (IOVA) PT Lowered to $23 at Stifel
Aug 9, 2024 06:59AM Iovanace Biotherapeutics (IOVA) PT Lowered to $24 at Baird
Jul 29, 2024 02:11AM Piper Sandler Downgrades Iovanace Biotherapeutics (IOVA) to Neutral
Jul 1, 2024 06:38AM H.C. Wainwright Reiterates Buy Rating on Iovanace Biotherapeutics (IOVA)
Jun 28, 2024 07:17AM Iovance Biotherapeutics (IOVA) Submits Marketing Authorization Application to EMA for Lifileucel
Jun 28, 2024 07:01AM Iovance Biotherapeutics (IOVA) Submits MAA to EMA for Lifileucel in Advanced Melanoma
View More Recent Stories